Medication reduces hot flushes in women on endocrine therapy after breast cancer: Aus study
The novel non-hormonal medication appeared well tolerated in the small trial, authors say
A Monash University-led trial shows a new medication significantly reduces vasomotor symptoms in women taking oral adjuvant endocrine therapy after breast cancer.
The drug, called Q-122, cut the number and severity of hot flushes and also improved sleep, according to findings published in The Lancet.Â
